Alexandria Venture Investments has supported the life science technology developer in its $88.9m series C round which has pushed total funding past $142m.
US-based life science technology developer Invaio Sciences has raised $88.9m for the close of a series C round featuring Alexandria Venture Investments, an investment vehicle for life sciences real estate investment trust Alexandria Real Estate Equities.
Venture capital firm Flagship Pioneering led the round with participation from Stage 1 Ventures and Bluwave Capital.
Founded by Flagship Pioneering in 2018, Invaio Sciences is developing technology and services to address critical issues in agriculture, nutrition and the environment. The company aims to…
